- Home
- BCYC vs MCS Comparison
BCYC vs MCS Comparison
Compare BCYC & MCS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- BCYC
- MCS
- Stock Information
- Founded
- BCYC 2009
- MCS 1935
- Country
- BCYC United Kingdom
- MCS United States
- Employees
- BCYC N/A
- MCS N/A
- Industry
- BCYC Biotechnology: Pharmaceutical Preparations
- MCS Movies/Entertainment
- Sector
- BCYC Health Care
- MCS Consumer Discretionary
- Exchange
- BCYC Nasdaq
- MCS Nasdaq
- Market Cap
- BCYC 620.7M
- MCS 549.0M
- IPO Year
- BCYC 2019
- MCS N/A
- Fundamental
- Price
- BCYC $8.56
- MCS $16.70
- Analyst Decision
- BCYC Buy
- MCS Strong Buy
- Analyst Count
- BCYC 8
- MCS 3
- Target Price
- BCYC $29.14
- MCS $24.00
- AVG Volume (30 Days)
- BCYC 331.4K
- MCS 256.8K
- Earning Date
- BCYC 05-01-2025
- MCS 05-01-2025
- Dividend Yield
- BCYC N/A
- MCS 1.69%
- EPS Growth
- BCYC N/A
- MCS N/A
- EPS
- BCYC N/A
- MCS N/A
- Revenue
- BCYC $35,275,000.00
- MCS $695,086,000.00
- Revenue This Year
- BCYC N/A
- MCS $10.75
- Revenue Next Year
- BCYC $18.29
- MCS $4.25
- P/E Ratio
- BCYC N/A
- MCS N/A
- Revenue Growth
- BCYC 30.76
- MCS 0.42
- 52 Week Low
- BCYC $8.20
- MCS $9.56
- 52 Week High
- BCYC $28.67
- MCS $23.16
- Technical
- Relative Strength Index (RSI)
- BCYC 29.39
- MCS 38.18
- Support Level
- BCYC $8.60
- MCS $16.15
- Resistance Level
- BCYC $9.69
- MCS $17.47
- Average True Range (ATR)
- BCYC 0.67
- MCS 0.46
- MACD
- BCYC 0.00
- MCS 0.15
- Stochastic Oscillator
- BCYC 6.05
- MCS 43.62
About BCYC Bicycle Therapeutics plc
Bicycle Therapeutics PLC is a clinical-stage biopharmaceutical company developing a novel class of medicines which are referred to as Bicycles. The Bicycles are synthetic short peptides constrained to form two loops that stabilize their structural geometry. Its initial internal programs are focused on oncology indications with high unmet medical needs. The company's product candidate, BT1718, is a Bicycle Toxin Conjugate, or BTC. The company has two segments: the United Kingdom and the United States. It derives maximum revenue from United States.
About MCS Marcus Corporation (The)
Marcus Corp is engaged in two business segments, which are Theatres and Hotels and Resorts. The Theatre segment operates multiscreen motion picture theatres in Wisconsin, Illinois, Iowa, Minnesota, Missouri, Nebraska, North Dakota, Ohio ands others, a family entertainment center in Wisconsin and a retail center in Missouri; Hotels and Resorts segment owns and operates full-service hotels and resorts in Wisconsin, Illinois, and Nebraska and manages full-service hotels, resorts and other properties in Wisconsin, Minnesota, Texas, Nevada, California, and North Carolina. It generates maximum revenue from the Theatres segment.